RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2019

Aug 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2019-07-30

Reporting Person: Arbuckle Stuart A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-30	Stock Option (right to buy)	$19.05	A	30000	Acquired	2029-07-29	Common Stock (30000)	Direct

Footnotes

F1: One-third of the options will vest on each one-year anniversary of the grant date, with the first one-third vesting on July 30, 2020.